MedPath

Kardak Tablet 40 mg

Registration Number: MAL08010726AZ

Approved
Approval ID

d49f61a896140624

Registration Number

MAL08010726AZ

Registration Date

Jul 7, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types1 type
Last UpdatedJul 7, 2025

PACKAGING INFORMATION (1)

10Tablet TabletsAvailable
Package Size: 10Tablet Tablets
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (1)

Simvastatin Ph.Eur.Active
Monograph: simvastatin ph.eur.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Kardak Tablet 40 mg - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform